Previous close | 19.48 |
Open | 19.24 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 18.97 - 19.45 |
52-week range | 12.13 - 20.94 |
Volume | |
Avg. volume | 2,193,924 |
Market cap | 18.713B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.09 |
Earnings date | 23 Oct 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 11 May 2023 |
1y target est | 19.50 |
Philips (PHG) expands its mobile C-arm lineup with Zenition 30, which provides surgeons with more control and customization.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Philips Zenition 30 in use Philips Zenition 30 product photo September 13, 2023 Offering surgeons greater flexibility, control, and personalization in C-arm operation and image acquisition, Philips’ new Zenition 30 reduces dependency on technician support for a wide variety of minimally invasive procedures Advanced imaging algorithms contribute to outstanding image quality and dose efficiency Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,